The article clearly states that Coralmyn would have been on the market, except for FDA approval. The demand is low, I agree, but regulatory overhead made the di

The article clearly states that Coralmyn would have been on the market, except for FDA approval. The demand is low, I agree, but regulatory overhead made the difference between producing something and producing nothing.